nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.319	0.428	CbGbCtD
Rabeprazole—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.294	0.395	CbGbCtD
Rabeprazole—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.131	0.177	CbGbCtD
Rabeprazole—Embolus—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0591	CcSEcCtD
Rabeprazole—Oesophageal stenosis—Riluzole—amyotrophic lateral sclerosis	0.00799	0.0319	CcSEcCtD
Rabeprazole—Carcinoma of lung—Riluzole—amyotrophic lateral sclerosis	0.00712	0.0284	CcSEcCtD
Rabeprazole—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.00616	0.0246	CcSEcCtD
Rabeprazole—Vestibular disorder—Riluzole—amyotrophic lateral sclerosis	0.00616	0.0246	CcSEcCtD
Rabeprazole—Iron deficiency anaemia—Riluzole—amyotrophic lateral sclerosis	0.00544	0.0217	CcSEcCtD
Rabeprazole—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0202	CcSEcCtD
Rabeprazole—Lansoprazole—MAPT—amyotrophic lateral sclerosis	0.00503	1	CrCbGaD
Rabeprazole—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.00445	0.0178	CcSEcCtD
Rabeprazole—Salivary gland enlargement—Riluzole—amyotrophic lateral sclerosis	0.00445	0.0178	CcSEcCtD
Rabeprazole—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0163	CcSEcCtD
Rabeprazole—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.00398	0.0159	CcSEcCtD
Rabeprazole—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0141	CcSEcCtD
Rabeprazole—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0132	CcSEcCtD
Rabeprazole—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0132	CcSEcCtD
Rabeprazole—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0127	CcSEcCtD
Rabeprazole—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00301	0.012	CcSEcCtD
Rabeprazole—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.00296	0.0118	CcSEcCtD
Rabeprazole—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00263	0.0105	CcSEcCtD
Rabeprazole—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00977	CcSEcCtD
Rabeprazole—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0089	CcSEcCtD
Rabeprazole—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0089	CcSEcCtD
Rabeprazole—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00869	CcSEcCtD
Rabeprazole—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00858	CcSEcCtD
Rabeprazole—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00838	CcSEcCtD
Rabeprazole—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00819	CcSEcCtD
Rabeprazole—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00801	CcSEcCtD
Rabeprazole—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00784	CcSEcCtD
Rabeprazole—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00776	CcSEcCtD
Rabeprazole—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00768	CcSEcCtD
Rabeprazole—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0076	CcSEcCtD
Rabeprazole—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00752	CcSEcCtD
Rabeprazole—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00752	CcSEcCtD
Rabeprazole—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00723	CcSEcCtD
Rabeprazole—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00716	CcSEcCtD
Rabeprazole—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00716	CcSEcCtD
Rabeprazole—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00696	CcSEcCtD
Rabeprazole—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00696	CcSEcCtD
Rabeprazole—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00696	CcSEcCtD
Rabeprazole—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0069	CcSEcCtD
Rabeprazole—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00684	CcSEcCtD
Rabeprazole—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00655	CcSEcCtD
Rabeprazole—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00655	CcSEcCtD
Rabeprazole—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00638	CcSEcCtD
Rabeprazole—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00623	CcSEcCtD
Rabeprazole—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00613	CcSEcCtD
Rabeprazole—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00581	CcSEcCtD
Rabeprazole—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00573	CcSEcCtD
Rabeprazole—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00565	CcSEcCtD
Rabeprazole—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00549	CcSEcCtD
Rabeprazole—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00546	CcSEcCtD
Rabeprazole—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00542	CcSEcCtD
Rabeprazole—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00542	CcSEcCtD
Rabeprazole—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00535	CcSEcCtD
Rabeprazole—Gout—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00528	CcSEcCtD
Rabeprazole—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00524	CcSEcCtD
Rabeprazole—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00521	CcSEcCtD
Rabeprazole—Cataract—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00518	CcSEcCtD
Rabeprazole—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00502	CcSEcCtD
Rabeprazole—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00499	CcSEcCtD
Rabeprazole—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00493	CcSEcCtD
Rabeprazole—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00493	CcSEcCtD
Rabeprazole—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00493	CcSEcCtD
Rabeprazole—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0049	CcSEcCtD
Rabeprazole—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00487	CcSEcCtD
Rabeprazole—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00487	CcSEcCtD
Rabeprazole—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00481	CcSEcCtD
Rabeprazole—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00476	CcSEcCtD
Rabeprazole—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00471	CcSEcCtD
Rabeprazole—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00453	CcSEcCtD
Rabeprazole—Coma—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0045	CcSEcCtD
Rabeprazole—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00446	CcSEcCtD
Rabeprazole—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00446	CcSEcCtD
Rabeprazole—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00432	CcSEcCtD
Rabeprazole—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00419	CcSEcCtD
Rabeprazole—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00419	CcSEcCtD
Rabeprazole—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00411	CcSEcCtD
Rabeprazole—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00409	CcSEcCtD
Rabeprazole—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00407	CcSEcCtD
Rabeprazole—Deafness—Riluzole—amyotrophic lateral sclerosis	0.001	0.004	CcSEcCtD
Rabeprazole—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000967	0.00386	CcSEcCtD
Rabeprazole—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000955	0.00381	CcSEcCtD
Rabeprazole—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000955	0.00381	CcSEcCtD
Rabeprazole—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000942	0.00376	CcSEcCtD
Rabeprazole—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000923	0.00368	CcSEcCtD
Rabeprazole—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0009	0.00359	CcSEcCtD
Rabeprazole—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00358	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00358	CcSEcCtD
Rabeprazole—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00358	CcSEcCtD
Rabeprazole—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00089	0.00355	CcSEcCtD
Rabeprazole—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00352	CcSEcCtD
Rabeprazole—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000866	0.00345	CcSEcCtD
Rabeprazole—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00333	CcSEcCtD
Rabeprazole—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000828	0.0033	CcSEcCtD
Rabeprazole—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000816	0.00326	CcSEcCtD
Rabeprazole—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000794	0.00317	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000791	0.00316	CcSEcCtD
Rabeprazole—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00078	0.00311	CcSEcCtD
Rabeprazole—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000775	0.00309	CcSEcCtD
Rabeprazole—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000775	0.00309	CcSEcCtD
Rabeprazole—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00076	0.00303	CcSEcCtD
Rabeprazole—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000755	0.00301	CcSEcCtD
Rabeprazole—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000745	0.00297	CcSEcCtD
Rabeprazole—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000736	0.00294	CcSEcCtD
Rabeprazole—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000725	0.00289	CcSEcCtD
Rabeprazole—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000725	0.00289	CcSEcCtD
Rabeprazole—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000716	0.00286	CcSEcCtD
Rabeprazole—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000714	0.00285	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000707	0.00282	CcSEcCtD
Rabeprazole—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000705	0.00281	CcSEcCtD
Rabeprazole—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000701	0.0028	CcSEcCtD
Rabeprazole—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000695	0.00277	CcSEcCtD
Rabeprazole—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000681	0.00272	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000677	0.0027	CcSEcCtD
Rabeprazole—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000677	0.0027	CcSEcCtD
Rabeprazole—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000674	0.00269	CcSEcCtD
Rabeprazole—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000674	0.00269	CcSEcCtD
Rabeprazole—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000672	0.00268	CcSEcCtD
Rabeprazole—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000663	0.00264	CcSEcCtD
Rabeprazole—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000659	0.00263	CcSEcCtD
Rabeprazole—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000652	0.0026	CcSEcCtD
Rabeprazole—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000648	0.00259	CcSEcCtD
Rabeprazole—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.000645	0.00257	CcSEcCtD
Rabeprazole—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000632	0.00252	CcSEcCtD
Rabeprazole—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000622	0.00248	CcSEcCtD
Rabeprazole—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00062	0.00248	CcSEcCtD
Rabeprazole—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000616	0.00246	CcSEcCtD
Rabeprazole—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000613	0.00244	CcSEcCtD
Rabeprazole—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000611	0.00244	CcSEcCtD
Rabeprazole—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000608	0.00243	CcSEcCtD
Rabeprazole—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00234	CcSEcCtD
Rabeprazole—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00058	0.00231	CcSEcCtD
Rabeprazole—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000563	0.00225	CcSEcCtD
Rabeprazole—Chills—Riluzole—amyotrophic lateral sclerosis	0.000557	0.00222	CcSEcCtD
Rabeprazole—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000554	0.00221	CcSEcCtD
Rabeprazole—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000548	0.00219	CcSEcCtD
Rabeprazole—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00054	0.00215	CcSEcCtD
Rabeprazole—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000532	0.00212	CcSEcCtD
Rabeprazole—Tension—Riluzole—amyotrophic lateral sclerosis	0.00053	0.00211	CcSEcCtD
Rabeprazole—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00211	CcSEcCtD
Rabeprazole—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000525	0.00209	CcSEcCtD
Rabeprazole—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000522	0.00208	CcSEcCtD
Rabeprazole—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000519	0.00207	CcSEcCtD
Rabeprazole—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000506	0.00202	CcSEcCtD
Rabeprazole—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000501	0.002	CcSEcCtD
Rabeprazole—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000499	0.00199	CcSEcCtD
Rabeprazole—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000496	0.00198	CcSEcCtD
Rabeprazole—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000493	0.00197	CcSEcCtD
Rabeprazole—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000487	0.00194	CcSEcCtD
Rabeprazole—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000485	0.00194	CcSEcCtD
Rabeprazole—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000484	0.00193	CcSEcCtD
Rabeprazole—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000483	0.00193	CcSEcCtD
Rabeprazole—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000477	0.0019	CcSEcCtD
Rabeprazole—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000475	0.00189	CcSEcCtD
Rabeprazole—Cough—Riluzole—amyotrophic lateral sclerosis	0.000471	0.00188	CcSEcCtD
Rabeprazole—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000468	0.00187	CcSEcCtD
Rabeprazole—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000466	0.00186	CcSEcCtD
Rabeprazole—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00046	0.00183	CcSEcCtD
Rabeprazole—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00046	0.00183	CcSEcCtD
Rabeprazole—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00046	0.00183	CcSEcCtD
Rabeprazole—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000458	0.00183	CcSEcCtD
Rabeprazole—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000454	0.00181	CcSEcCtD
Rabeprazole—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00045	0.00179	CcSEcCtD
Rabeprazole—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000444	0.00177	CcSEcCtD
Rabeprazole—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00176	CcSEcCtD
Rabeprazole—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00176	CcSEcCtD
Rabeprazole—Shock—Riluzole—amyotrophic lateral sclerosis	0.000434	0.00173	CcSEcCtD
Rabeprazole—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000432	0.00172	CcSEcCtD
Rabeprazole—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00172	CcSEcCtD
Rabeprazole—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000426	0.0017	CcSEcCtD
Rabeprazole—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00042	0.00168	CcSEcCtD
Rabeprazole—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000412	0.00164	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000402	0.0016	CcSEcCtD
Rabeprazole—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000399	0.00159	CcSEcCtD
Rabeprazole—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000396	0.00158	CcSEcCtD
Rabeprazole—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000393	0.00157	CcSEcCtD
Rabeprazole—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000392	0.00156	CcSEcCtD
Rabeprazole—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000388	0.00155	CcSEcCtD
Rabeprazole—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000383	0.00153	CcSEcCtD
Rabeprazole—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000377	0.0015	CcSEcCtD
Rabeprazole—Pain—Riluzole—amyotrophic lateral sclerosis	0.000377	0.0015	CcSEcCtD
Rabeprazole—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000363	0.00145	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00036	0.00144	CcSEcCtD
Rabeprazole—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00035	0.0014	CcSEcCtD
Rabeprazole—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000348	0.00139	CcSEcCtD
Rabeprazole—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000348	0.00139	CcSEcCtD
Rabeprazole—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000325	0.0013	CcSEcCtD
Rabeprazole—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000316	0.00126	CcSEcCtD
Rabeprazole—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000312	0.00124	CcSEcCtD
Rabeprazole—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000302	0.0012	CcSEcCtD
Rabeprazole—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00116	CcSEcCtD
Rabeprazole—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00028	0.00112	CcSEcCtD
Rabeprazole—Rash—Riluzole—amyotrophic lateral sclerosis	0.000278	0.00111	CcSEcCtD
Rabeprazole—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000278	0.00111	CcSEcCtD
Rabeprazole—Headache—Riluzole—amyotrophic lateral sclerosis	0.000276	0.0011	CcSEcCtD
Rabeprazole—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000262	0.00104	CcSEcCtD
